Skip to main content

Byrna Technologies Inc

For the period ended Feb 29, 2024. Filed Apr 5, 2024.

View on SEC.gov

About this filing

A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.

Feb 29, 2024 · Filed Apr 5, 2024

BYRN$3.83+2.4%Stored close · as of Nov 6, 2026
See the whole filing, with its images and exhibits

Cover page

Show cover page

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 10-Q

☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the quarterly period ended February 29, 2024

☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the transition period from _________ to _________

Commission File No.333-132456

Byrna Technologies Inc.
(Exact name of registrant as specified in its charter)
Delaware71-1050654
(State or other jurisdiction of incorporation or(I.R.S. Employer Identification No.)
organization)
100 Burtt Road, Suite 115
Andover, MA 01810
(Address of Principal Executive Offices, including zip code)
(978) 868-5011
(Registrant’s telephone number, including area code)

Securities registered pursuant to Section 12(b) of the Act:

Title of each classTrading Symbol(s)Name of each exchange on which registered
Common stock, $0.001, par value per shareBYRNThe Nasdaq Stock Market

Securities registered pursuant to Section 12(g) of the Act: None.

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes ☒ No ☐

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). Yes ☒ No ☐

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act.

Large accelerated filer ☐ Accelerated filer ☐Non-accelerated filer ☒ Smaller reporting company☒ Emerging growth company☐

☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act): Yes☐ No ☒

As of April 1, 2024, the Company had 24,924,389 issued and 22,736,497 outstanding shares of common stock.

TABLE OF CONTENTS

Page
PART 1 – FINANCIAL INFORMATION2
Item 1.Condensed Consolidated Financial Statements2
Condensed Consolidated Balance Sheets as of February 29, 2024 (unaudited) and November 30, 20232
Condensed Consolidated Statements of Operations and Comprehensive Loss for the Three Months Ended February 29, 2024 and February 28, 2023 (unaudited)2
Condensed Consolidated Statements of Cash Flows for the Three Months Ended February 29, 2024 and February 28, 2023 (unaudited)4
Condensed Consolidated Statements of Changes in Stockholders’ Equity for the Three Months Ended February 29, 2024 and February 28, 2023 (unaudited)5
Notes to Condensed Consolidated Financial Statements6
Item 2.Management’s Discussion and Analysis of Financial Condition and Results of Operations18
Item 3.Quantitative and Qualitative Disclosures about Market Risk23
Item 4.Controls and Procedures23
PART II – OTHER INFORMATION24
Item 1.Legal Proceedings24
Item 1A.Risk Factors24
Item 2.Unregistered Sales of Equity Securities and Use of Proceeds24
Item 3.Defaults Upon Senior Securities24
Item 4.Mine Safety Disclosures24
Item 5.Other Information24
Item 6.Exhibits25
SIGNATURES26

PART 1–** FINANCIAL INFORMATION**

ITEM 1.Condensed Consolidated Financial Statements

Condensed Consolidated Balance Sheets

(Amounts in thousands, except share and per share data)

February 29,November 30,
20242023
Unaudited
ASSETS
CURRENT ASSETS
Cash and cash equivalents$24,176$20,498
Accounts receivable, net1,5362,945
Inventory, net12,12813,890
Prepaid expenses and other current assets1,131868
Total current assets38,97138,201
LONG TERM ASSETS
Intangible assets, net3,5103,583
Deposits for equipment1,2691,163
Right-of-use asset, net1,6881,805
Property and equipment, net3,5913,803
Goodwill2,2582,258
Loan to joint venture1,4311,473
Other assets2428
TOTAL ASSETS$52,742$52,314
LIABILITIES
CURRENT LIABILITIES
Accounts payable and accrued liabilities$5,131$6,158
Operating lease liabilities, current641644
Deferred revenue, current2,5951,844
Total current liabilities8,3678,646
LONG TERM LIABILITIES
Deferred revenue, non-current7191
Operating lease liabilities, non-current1,1351,258
Total liabilities9,5739,995
COMMITMENTS AND CONTINGENCIES (NOTE 18)
STOCKHOLDERS’ EQUITY
Preferred stock, $0.001 par value, 5,000,000 shares authorized, no shares issued——
Common stock, $0.001 par value, 50,000,000 shares authorized. 24,375,754 shares issued and 22,209,767 shares outstanding as of February 29, 2024 and, 24,168,014 shares issued and 22,002,027 outstanding as of November 30, 20232424
Additional paid-in capital131,374130,426
Treasury stock (2,165,987 shares purchased as of February 29, 2024 and November 30, 2023)(17,500)(17,500)
Accumulated deficit(69,558)(69,575)
Accumulated other comprehensive loss(1,171)(1,056)
Total Stockholders’ Equity43,16942,319
TOTAL LIABILITIES AND STOCKHOLDERS’ EQUITY$52,742$52,314

Condensed Consolidated Statements of Operations and Comprehensive Loss

(Amounts in thousands except share and per share data)

For the Three Months Ended
February 29,February 28,
20242023
Net revenue$16,654$8,411
Cost of goods sold7,0153,165
Gross profit9,6395,246
Operating expenses9,8037,240
LOSS FROM OPERATIONS(164)(1,994)
OTHER INCOME (EXPENSE)
Foreign currency transaction loss(58)(136)
Interest income280143
Loss from joint venture(42)(167)
Other income (expense)1(58)
INCOME (LOSS) BEFORE INCOME TAXES17(2,212)
Income tax benefit—59
NET INCOME (LOSS)17(2,153)
Foreign currency translation adjustment for the period(115)(585)
COMPREHENSIVE LOSS$(98)$(2,738)
Basic net income (loss) per share$0.00$(0.10)
Diluted net income (loss) per share$0.00$(0.10)
Weighted-average number of common shares outstanding - basic22,035,24921,860,200
Weighted-average number of common shares outstanding - diluted22,838,82721,860,200

Condensed Consolidated Statements of Cash Flows

(Amounts in thousands)

For the Three Months Ended
February 29,February 28,
20242023
CASH FLOWS FROM OPERATING ACTIVITIES
Net income (loss) for the period$17$(2,153)
Adjustments to reconcile net income (loss) to net cash provided by (used in) operating activities:
Stock-based compensation expense9381,464
Depreciation and amortization338276
Amortization of debt issuance costs4—
Operating lease costs117362
Loss from joint venture42167
Changes in assets and liabilities:
Accounts receivable1,4091,487
Deferred revenue731525
Inventory1,762(2,896)
Prepaid expenses and other current assets(263)(418)
Other assets—13
Accounts payable and accrued liabilities(1,027)(1,823)
Operating lease liabilities(126)(375)
NET CASH PROVIDED BY (USED IN) OPERATING ACTIVITIES3,942(3,371)
CASH FLOWS FROM INVESTING ACTIVITIES
Purchases of property and equipment(171)(206)
Equity method investment in joint venture—(520)
Loan to joint venture—(1,556)
NET CASH USED IN INVESTING ACTIVITIES(171)(2,282)
CASH FLOWS FROM FINANCING ACTIVITIES
Proceeds from stock option exercises10—
NET CASH PROVIDED BY FINANCING ACTIVITIES10—
Effects of foreign currency exchange rate changes(103)11
NET INCREASE (DECREASE) IN CASH AND CASH EQUIVALENTS FOR THE PERIOD3,678(5,642)
CASH AND CASH EQUIVALENTS, BEGINNING OF PERIOD20,49820,068
CASH AND CASH EQUIVALENTS END OF PERIOD$24,176$14,426

Condensed Consolidated Statements of Changes in Stockholders’** Equity**

For the Three Months Ended February 29, 2024 and February 28, 2023

(Amounts in thousands except share numbers)

Additional · Treasury · Accumulated Other
Common Stock · Paid-in · Stock · Accumulated · Comprehensive
Shares$CapitalShares$DeficitLossTotal
Balance, November 30, 202324,168,014$24$130,426(2,165,987)$(17,500)$(69,575)$(1,056)$42,319
Stock-based compensation——938————938
Issuance of common stock pursuant to exercise of stock options167,967—10————10
Issuance of common stock pursuant to vesting of restricted stock units39,773———————
Net income—————17—17
Foreign currency translation——————(115)(115)
Balance, February 29, 202424,375,754$24$131,374(2,165,987)$(17,500)$(69,558)$(1,171)$43,169
Balance, November 30, 202224,018,612$23$125,474(2,165,987)$(17,500)$(61,383)$(620)$45,994
Issuance of common stock pursuant to vesting of restricted stock units13,636———————
Stock-based compensation——1,464————1,464
Net loss—————(2,153)—(2,153)
Foreign currency translation——————(585)(585)
Balance, February 28, 202324,032,248$23$126,938(2,165,987)$(17,500)$(63,536)$(1,205)$44,720
ContentsView on SEC.gov

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.